"Liquid Biopsy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Obtaining material for pathological examination and analysis, from bodily fluids. Material retrieved includes CELL-FREE NUCLEIC ACIDS; CELL-DERIVED MICROPARTICLES; EXOSOMES; CIRCULATING NEOPLASM CELLS; and other circulating cells and CELLULAR STRUCTURES.
| Descriptor ID |
D000073890
|
| MeSH Number(s) |
E01.370.225.500.384.100.396 E01.370.225.998.054.396 E05.200.500.384.100.396 E05.200.998.054.396 E05.242.384.100.396
|
| Concept/Terms |
Liquid Biopsy- Liquid Biopsy
- Biopsies, Liquid
- Biopsy, Liquid
- Liquid Biopsies
|
Below are MeSH descriptors whose meaning is more general than "Liquid Biopsy".
Below are MeSH descriptors whose meaning is more specific than "Liquid Biopsy".
This graph shows the total number of publications written about "Liquid Biopsy" by people in this website by year, and whether "Liquid Biopsy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liquid Biopsy" by people in Profiles.
-
Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor. Mol Cancer Ther. 2020 12; 19(12):2598-2611.
-
Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy. Clin Lung Cancer. 2019 11; 20(6):e597-e600.